NO325155B1 - Nye desloratadinhemisulfat, fremgangsmate for deres syntese og farmasoytiske preparater derav - Google Patents
Nye desloratadinhemisulfat, fremgangsmate for deres syntese og farmasoytiske preparater derav Download PDFInfo
- Publication number
- NO325155B1 NO325155B1 NO20032314A NO20032314A NO325155B1 NO 325155 B1 NO325155 B1 NO 325155B1 NO 20032314 A NO20032314 A NO 20032314A NO 20032314 A NO20032314 A NO 20032314A NO 325155 B1 NO325155 B1 NO 325155B1
- Authority
- NO
- Norway
- Prior art keywords
- desloratadine
- formula
- hemisulphate
- loratadine
- synthesis
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 18
- 230000015572 biosynthetic process Effects 0.000 title abstract description 7
- 238000003786 synthesis reaction Methods 0.000 title abstract description 6
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- BFUKZAZVGNXTDM-UHFFFAOYSA-N 8-chloro-11-piperidin-4-ylidene-5,6-dihydrobenzo[1,2]cyclohepta[2,4-b]pyridine;sulfuric acid Chemical compound OS(O)(=O)=O.C=1C(Cl)=CC=C2C=1CCC1=CC=CN=C1C2=C1CCNCC1.C=1C(Cl)=CC=C2C=1CCC1=CC=CN=C1C2=C1CCNCC1 BFUKZAZVGNXTDM-UHFFFAOYSA-N 0.000 title description 2
- JAUOIFJMECXRGI-UHFFFAOYSA-N Neoclaritin Chemical class C=1C(Cl)=CC=C2C=1CCC1=CC=CN=C1C2=C1CCNCC1 JAUOIFJMECXRGI-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000002253 acid Substances 0.000 claims abstract description 7
- 229960001271 desloratadine Drugs 0.000 claims description 29
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 claims description 19
- 239000000243 solution Substances 0.000 claims description 16
- 229960003088 loratadine Drugs 0.000 claims description 15
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical group OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 12
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 150000007522 mineralic acids Chemical class 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 2
- 239000007864 aqueous solution Chemical group 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims description 2
- 238000009413 insulation Methods 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 abstract description 9
- 230000003266 anti-allergic effect Effects 0.000 abstract description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- WGTYBPLFGIVFAS-UHFFFAOYSA-M tetramethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)C WGTYBPLFGIVFAS-UHFFFAOYSA-M 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- -1 desloratadine dihydrogen chloride salt Chemical class 0.000 description 3
- VFNGKCDDZUSWLR-UHFFFAOYSA-L disulfate(2-) Chemical compound [O-]S(=O)(=O)OS([O-])(=O)=O VFNGKCDDZUSWLR-UHFFFAOYSA-L 0.000 description 3
- VFNGKCDDZUSWLR-UHFFFAOYSA-N disulfuric acid Chemical compound OS(=O)(=O)OS(O)(=O)=O VFNGKCDDZUSWLR-UHFFFAOYSA-N 0.000 description 3
- 238000000265 homogenisation Methods 0.000 description 3
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
- 238000004313 potentiometry Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- HCLXLZGAYCTHQJ-UHFFFAOYSA-N 1h-cyclohepta[b]pyridine Chemical compound C1=CC=CC=C2NC=CC=C21 HCLXLZGAYCTHQJ-UHFFFAOYSA-N 0.000 description 1
- VLXSCTINYKDTKR-UHFFFAOYSA-N 8-chloro-11-(1-methylpiperidin-4-ylidene)-5,6-dihydrobenzo[1,2]cyclohepta[2,4-b]pyridine Chemical compound C1CN(C)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 VLXSCTINYKDTKR-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 159000000021 acetate salts Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- SLUNEGLMXGHOLY-UHFFFAOYSA-N benzene;hexane Chemical compound CCCCCC.C1=CC=CC=C1 SLUNEGLMXGHOLY-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000000938 histamine H1 antagonist Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000000954 titration curve Methods 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0004701A HU226998B1 (en) | 2000-11-23 | 2000-11-23 | Desloratadine hemisulphate, process for the preparation thereof and pharmaceutical compositions containing the same |
| PCT/HU2001/000111 WO2002042290A1 (en) | 2000-11-23 | 2001-11-14 | New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20032314D0 NO20032314D0 (no) | 2003-05-22 |
| NO20032314L NO20032314L (no) | 2003-07-18 |
| NO325155B1 true NO325155B1 (no) | 2008-02-11 |
Family
ID=89978790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20032314A NO325155B1 (no) | 2000-11-23 | 2003-05-22 | Nye desloratadinhemisulfat, fremgangsmate for deres syntese og farmasoytiske preparater derav |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7196195B2 (pl) |
| EP (1) | EP1347965B1 (pl) |
| JP (1) | JP4427249B2 (pl) |
| CN (1) | CN1199968C (pl) |
| AT (1) | ATE316525T1 (pl) |
| AU (1) | AU2002218422A1 (pl) |
| CA (1) | CA2425422C (pl) |
| CY (1) | CY1105595T1 (pl) |
| CZ (1) | CZ304694B6 (pl) |
| DE (1) | DE60116902T2 (pl) |
| DK (1) | DK1347965T3 (pl) |
| ES (1) | ES2257467T3 (pl) |
| HU (1) | HU226998B1 (pl) |
| NO (1) | NO325155B1 (pl) |
| PL (1) | PL206973B1 (pl) |
| RU (1) | RU2285001C2 (pl) |
| SK (1) | SK285715B6 (pl) |
| UA (1) | UA74858C2 (pl) |
| WO (1) | WO2002042290A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7678908B2 (en) | 2002-04-15 | 2010-03-16 | Sun Pharmaceutical Industries Limited | Process of preparing desaloratadine |
| JP2005539010A (ja) | 2002-08-05 | 2005-12-22 | サンド・アクチエンゲゼルシヤフト | デスロラタジンヘミフマレートの新規な塩及び多形体 |
| JP4501015B2 (ja) | 2004-03-17 | 2010-07-14 | 味の素株式会社 | アミノピリミジン化合物の製造方法 |
| EA011894B1 (ru) * | 2004-07-07 | 2009-06-30 | Эгиш Дьёдьсердьяр Нирт. | Новая псевдополиморфная форма деслоратадина, образованная с диоксидом углерода |
| CA2541045A1 (en) * | 2006-03-24 | 2007-09-24 | Pharmascience Inc. | A descarbonylethoxyloratadine containing pharmaceutical composition |
| EP2837631A1 (en) * | 2013-08-14 | 2015-02-18 | Merck & Cie | New stable salt of 5,10-methylene-(6R)-tetrahydrofolic acid |
| MX2022005102A (es) * | 2019-10-31 | 2022-05-30 | Jd Bioscience Inc | Compuesto triciclico y uso farmaceutico del mismo. |
| CN115785065A (zh) * | 2022-12-02 | 2023-03-14 | 山东达因海洋生物制药股份有限公司 | 一种地氯雷他定共晶及其制备方法与应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4282233B1 (en) * | 1980-06-19 | 2000-09-05 | Schering Corp | Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines |
| AU570306B2 (en) * | 1984-02-15 | 1988-03-10 | Schering Corporation | 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridine and its salts. |
| DE3677842D1 (de) * | 1985-05-13 | 1991-04-11 | Schering Corp | Verfahren zur herstellung von piperidyliden-dihydrodibenzo(a,d)zykloheptenen und deren azoderivate, so hergestellte verbindungen und ihre anwendung zur vorbereitung von heilmitteln. |
| EP0656348B1 (de) * | 1993-12-03 | 2000-05-03 | F. Hoffmann-La Roche Ag | Essigsäurederivate als Arzneimittel |
| GB9709945D0 (en) * | 1997-05-17 | 1997-07-09 | Glaxo Group Ltd | A novel salt |
-
2000
- 2000-11-23 HU HU0004701A patent/HU226998B1/hu unknown
-
2001
- 2001-11-14 CZ CZ2003-1321A patent/CZ304694B6/cs unknown
- 2001-11-14 JP JP2002544424A patent/JP4427249B2/ja not_active Expired - Lifetime
- 2001-11-14 DE DE60116902T patent/DE60116902T2/de not_active Expired - Lifetime
- 2001-11-14 RU RU2003118425/04A patent/RU2285001C2/ru active
- 2001-11-14 AU AU2002218422A patent/AU2002218422A1/en not_active Abandoned
- 2001-11-14 US US10/432,387 patent/US7196195B2/en not_active Expired - Lifetime
- 2001-11-14 EP EP01997485A patent/EP1347965B1/en not_active Expired - Lifetime
- 2001-11-14 AT AT01997485T patent/ATE316525T1/de active
- 2001-11-14 UA UA2003065756A patent/UA74858C2/uk unknown
- 2001-11-14 ES ES01997485T patent/ES2257467T3/es not_active Expired - Lifetime
- 2001-11-14 DK DK01997485T patent/DK1347965T3/da active
- 2001-11-14 CN CNB018193382A patent/CN1199968C/zh not_active Expired - Lifetime
- 2001-11-14 SK SK566-2003A patent/SK285715B6/sk not_active IP Right Cessation
- 2001-11-14 WO PCT/HU2001/000111 patent/WO2002042290A1/en active IP Right Grant
- 2001-11-14 PL PL362126A patent/PL206973B1/pl unknown
- 2001-11-14 CA CA002425422A patent/CA2425422C/en not_active Expired - Lifetime
-
2003
- 2003-05-22 NO NO20032314A patent/NO325155B1/no not_active IP Right Cessation
-
2006
- 2006-03-29 CY CY20061100435T patent/CY1105595T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU226998B1 (en) | 2010-04-28 |
| DE60116902D1 (de) | 2006-04-13 |
| EP1347965B1 (en) | 2006-01-25 |
| HUP0004701A2 (hu) | 2002-11-28 |
| WO2002042290A1 (en) | 2002-05-30 |
| CN1199968C (zh) | 2005-05-04 |
| CZ20031321A3 (cs) | 2003-08-13 |
| EP1347965A1 (en) | 2003-10-01 |
| SK5662003A3 (en) | 2003-10-07 |
| CA2425422A1 (en) | 2002-05-30 |
| RU2285001C2 (ru) | 2006-10-10 |
| PL206973B1 (pl) | 2010-10-29 |
| NO20032314D0 (no) | 2003-05-22 |
| UA74858C2 (en) | 2006-02-15 |
| ES2257467T3 (es) | 2006-08-01 |
| CN1476443A (zh) | 2004-02-18 |
| JP4427249B2 (ja) | 2010-03-03 |
| CZ304694B6 (cs) | 2014-09-03 |
| PL362126A1 (pl) | 2004-10-18 |
| HU0004701D0 (pl) | 2001-02-28 |
| JP2004514675A (ja) | 2004-05-20 |
| US20050203116A1 (en) | 2005-09-15 |
| CY1105595T1 (el) | 2010-07-28 |
| ATE316525T1 (de) | 2006-02-15 |
| AU2002218422A1 (en) | 2002-06-03 |
| NO20032314L (no) | 2003-07-18 |
| SK285715B6 (sk) | 2007-06-07 |
| DE60116902T2 (de) | 2006-08-24 |
| CA2425422C (en) | 2009-11-10 |
| US7196195B2 (en) | 2007-03-27 |
| DK1347965T3 (da) | 2006-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ554119A (en) | Process for the preparation of 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide | |
| AP708A (en) | Processes and intermediates for preparing 1-Benzyl-4-((5,6-Dimethoxy-1-Incanon)-2-Y1) Methylpiperidine. | |
| KR100742482B1 (ko) | 피리딘-1-옥시드 유도체 및 이의 약제학적으로 유효한화합물로의 변환방법 | |
| NO325155B1 (no) | Nye desloratadinhemisulfat, fremgangsmate for deres syntese og farmasoytiske preparater derav | |
| AU751629B2 (en) | Process for the preparation of a piperazine derivative | |
| TWI355384B (en) | Method for preparing acid addition salts of polyac | |
| KR20040099361A (ko) | 약제학적 활성 화합물(그라니세트론)의 제조방법 | |
| NO309035B1 (no) | Ny fremgangsmÕte for fremstilling av ropivacainhydrokloridmonohydrat | |
| BG109814A (bg) | Нова псевдополиморфна форма на деслоратадин образувана с въглероден диоксид | |
| US3936459A (en) | 1',4'-Dihydro-1-methyl-spiro [piperidine and pyrrolidine-2,3'(2'H)quinoline]-2'-one compounds | |
| AU619129B2 (en) | Process for the preparation of methyl-quinoline derivatives | |
| KR100453379B1 (ko) | 피페리딘 유도체의 제조방법 | |
| JP3635345B2 (ja) | 縮合インダン化合物又はその塩 | |
| Elati et al. | Polymorphic study of donepezil hydrobromide | |
| DE102006059314A1 (de) | Verfahren zur Herstellung von [4-({3,3-Dimethyl-5-[4-(trifluormethyl)-phenyl]-2,3-dihydro-1H-indol-1-yl}sulfonyl)-2-methylphenoxy]essigsäure | |
| NO115783B (pl) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |